ProQR Therapeutics N.V.

Factors to consider:

• Earnings expected soon, date: 2026-05-14 bmo
• Total employees count: 59 as of 2014
• Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

• 2025-12-31 to 2026-12-31 estimated range: [1.47$, 3.34$]
• 2026-12-31 to 2027-12-31 estimated range: [1.40$, 3.24$]

Financial Metrics affecting the PRQR estimates:

• Positive: with PPE of -4.6 at the end of fiscal year the price was neutral
• Negative: negative Operating income
• Negative: Operating cash flow per share per price, % of -26.69 <= 0.07
• Positive: 42.60 < Shareholder equity ratio, % of 43.79 <= 64.25
• Positive: Investing cash flow per share per price, % of -0.52 > -0.65
• Positive: Inventory ratio change, % of -53.45 <= -0.75
• Positive: Industry inventory ratio change (median), % of 0 <= 0
• Negative: negative Net income